January 19, 2025 - 22:11

Investors brace for a volatile ride as President-elect Donald Trump’s second term gets underway on Monday, bringing the promise of significant policy shifts. Market analysts are closely examining which sectors may emerge as winners and losers under the incoming administration.
Historically, Trump's policies have had a profound impact on various industries, with energy, defense, and financial sectors often benefiting from his administration's initiatives. The anticipated focus on deregulation and tax cuts is expected to give a boost to these areas, attracting investor interest. Conversely, sectors such as technology and healthcare may face headwinds due to potential regulatory changes and shifts in trade policies.
As the new term unfolds, investors are advised to stay alert and agile, ready to adapt their strategies in response to the unfolding political landscape. The uncertainty surrounding Trump's agenda, combined with the ongoing economic recovery, suggests that volatility will be a defining feature of the markets in the coming months.
November 20, 2026 - 02:05
Docusign to Release Third Quarter Financial Results on December 3, 2026Docusign has announced that it will share its financial results for the third quarter of fiscal 2027 after the U.S. markets close on Thursday, December 3, 2026. Following the release, the company...
November 19, 2026 - 01:35
Royal Gold Expands Board with Mining Veteran Harry Kenyon-SlaneyDENVER, November 18, 2026--Royal Gold has taken a significant step in enhancing its leadership by appointing Harry Kenyon-Slaney to its Board of Directors. Kenyon-Slaney brings a wealth of...
November 18, 2026 - 00:46
Ramon.Space Secures $124 Million to Boost Space ComputingRamon.Space has successfully raised $124 million in a Series B funding round aimed at enhancing its onboard computing systems tailored for the space industry. This significant investment will...
November 17, 2026 - 09:36
Harbour BioMed Welcomes Dr. Sanjay Keswani as Neuroscience Scientific AdvisorHarbour BioMed has announced the addition of Dr. Sanjay Keswani to its team as a Scientific Advisor in the field of Neuroscience. Dr. Keswani brings a wealth of experience and expertise, which will...